WGS
GeneDx Holdings Corp.
$99.01
+$2.75(+2.86%)
32
Overall
20
Value
18
Tech
60
Quality
Market Cap
$4.15B
Volume
574.99K
52W Range
$55.17 - $170.87
Target Price
$170.89
Company Overview
| Mkt Cap | $4.15B | Price | $99.01 |
| Volume | 574.99K | Change | +2.86% |
| P/E Ratio | -79.3 | Open | $96.86 |
| Revenue | $305.4M | Prev Close | $96.26 |
| Net Income | $-52.3M | 52W Range | $55.17 - $170.87 |
| Div Yield | N/A | Target | $170.89 |
| Overall | 32 | Value | 20 |
| Quality | 60 | Technical | 18 |
No chart data available
About GeneDx Holdings Corp.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company is headquartered in Stamford, Connecticut.
Latest News
BTIG Sticks to Its Buy Rating for GeneDx Holdings (WGS)
TipRanks Auto-Generated Intelligence Newsdesk•14 days ago
Analysts Are Bullish on These Healthcare Stocks: Kymera Therapeutics (KYMR), GeneDx Holdings (WGS)
Christine Brown•18 days ago
Cathie Wood Doubles Down on High-Potential Biotech Plays
Sheryl Sheth•21 days ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Alnylam Pharma (ALNY), GeneDx Holdings (WGS) and Masimo (MASI)
Catie Powers•22 days ago
Analysts Offer Insights on Healthcare Companies: Quanterix (QTRX), Indivior (INDV) and GeneDx Holdings (WGS)
Catie Powers•a month ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | WGS | $99.01 | +2.9% | 574.99K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |